[1]
“Hybrid Red Blood Cell–Tumor Cell Membrane-Coated Nanoparticles for Cancer Therapy: Biological Principles, Therapeutic Applications, and Translational Challenges”, World Journal of Current Med and Pharm Research, vol. 8, no. 2, pp. 88–100, Jul. 2026, doi: 10.37022/wjcmpr.v8i2.403.